Pharmacogenetic Testing (Drug-Gene Testing)

Pharmacogenetic testing reads variants in a set of genes that control how your body breaks down, transports or reacts to medicines. The result classifies you, for each gene, as a poor, intermediate, normal, rapid or ultrarapid metaboliser, or as a carrier of a variant linked to a severe drug reaction.

For certain drug and gene pairs the result clearly changes what should be prescribed or at what dose. For many others the link is weak, and genes are only one influence on drug response alongside age, kidney and liver function, other medicines and whether tablets are taken.

What Pharmacogenetic Testing (Drug-Gene Testing) shows

Typical panels cover CYP2D6, CYP2C19, CYP2C9, CYP3A5, SLCO1B1, VKORC1, TPMT, NUDT15, DPYD, UGT1A1 and the immune markers HLA-B*57:01 and HLA-B*15:02. The pairs with the strongest guideline support include CYP2C19 and clopidogrel after a coronary stent, DPYD before fluorouracil or capecitabine chemotherapy, TPMT and NUDT15 before azathioprine or mercaptopurine, HLA-B*57:01 before abacavir, HLA-B*15:02 before carbamazepine in people of Asian ancestry, SLCO1B1 and statin muscle side effects, CYP2D6 and codeine or tramadol, and CYP2D6 and CYP2C19 for several antidepressants.

When Pharmacogenetic Testing (Drug-Gene Testing) is recommended

• Before chemotherapy with fluoropyrimidines, to avoid life-threatening toxicity
• After a coronary stent when clopidogrel is planned
• Before starting thiopurine drugs for inflammatory bowel disease, leukaemia or autoimmune disease
• People who have had severe side effects or no effect from standard doses of antidepressants, opioids or other medicines
• Before abacavir, carbamazepine or allopurinol in at-risk ancestry groups
• People on many long-term medicines who want a result kept on file for future prescribing

Limits and situations where another test is better:

• It does not predict allergies such as penicillin allergy, or most side effects
• It cannot tell which antidepressant will work for you; at best it guides dose and flags a few drugs to avoid
• It does not assess disease risk; that is a different kind of genetic test
• Direct-to-consumer reports may miss important variants, particularly CYP2D6 copy number changes and variants more frequent in non-European populations
• Drug interactions can override your genetic result and must be reviewed separately

How to prepare

• No fasting is needed and you should keep taking your usual medicines
• For a cheek swab, do not eat, drink, smoke or chew gum for 30 minutes beforehand
• Bring a full list of medicines, supplements and past drug reactions
• Tell the team if you have had a bone marrow or liver transplant, which can alter which DNA is relevant

What happens during the test

A blood sample from the arm or a cheek swab is taken in about 5 minutes. The laboratory extracts DNA and analyses the panel by genotyping or sequencing. Nothing else is required of you. A pre-test conversation should cover what the test can and cannot tell you and how the data will be stored.

Results and next steps

Reports usually arrive in 1 to 3 weeks; single urgent tests such as DPYD can be returned within a few days. A good report lists your genotype, the predicted phenotype and drug-by-drug advice based on CPIC or Dutch working group guidelines. A clinical pharmacologist or pharmacist should go through it with your medicine list. Never change or stop a medicine yourself on the basis of the report.

• Test time: 5 minutes for the sample
• Results ready: 1 to 3 weeks; a few days for urgent single-gene tests
• Back to everyday activity: None

Safety and risks

• Minor bruising from the blood draw
• Over-interpretation leading to needless medicine changes
• Genetic data privacy; ask who stores your data and for how long
• False reassurance when a rare variant was not included in the panel

Arranging Pharmacogenetic Testing (Drug-Gene Testing) in Türkiye

The test alone is not worth a journey, but it fits easily into a check-up or a pre-treatment work-up in Istanbul, for instance before chemotherapy or after stenting. Because results can take 1 to 3 weeks, arrange for the report and a remote consultation to follow you home, and give a copy to your own doctor and pharmacist.

Send your previous reports and the question you want answered and a Clinic-Y coordinator replies within 24 hours with suitable teams and written, all-inclusive proposals side by side. Reviewing your case is free.

Frequently Asked Questions